How should an 8-year-old boy with fever, headache, and a positive rapid SARS‑CoV‑2 test be evaluated and managed?

Management of an 8-Year-Old with Fever, Headache, and Positive COVID-19 Test

This child requires immediate screening for Multisystem Inflammatory Syndrome in Children (MIS-C) with Tier 1 laboratory testing, and should be admitted to the hospital if any concerning features are present, because MIS-C can be rapidly fatal and up to 20% of affected children develop coronary artery abnormalities. 1, 2

Immediate Clinical Assessment

Red Flags Requiring Hospital Admission

Admit immediately if any of the following are present:

• Neurologic changes: altered mental status, confusion, encephalopathy, focal deficits, meningismus, or papilledema 1, 3
• Abnormal vital signs: tachycardia or tachypnea for age 1, 3
• Respiratory distress of any severity 1
• Persistent fever: temperature ≥38.0°C lasting ≥24 hours 1, 2, 3
• Gastrointestinal symptoms: abdominal pain, vomiting, or diarrhea 1
• Mucocutaneous findings: rash, conjunctivitis, oral mucosal changes (red/cracked lips, strawberry tongue) 1
• Signs of shock or hypotension 1
• Dehydration or inability to maintain oral intake 1

The combination of fever and headache in this COVID-positive child is particularly concerning because headache is recognized as an "additional feature" of MIS-C, and neurologic involvement (including severe headache) has been increasingly reported in select MIS-C patients. 1, 3

Tier 1 Laboratory Screening (Obtain Immediately)

All children under investigation for MIS-C require the following initial tests: 1

• Complete blood count with differential (assess for lymphopenia, neutrophilia, thrombocytopenia) 1
• Comprehensive metabolic panel (evaluate for hyponatremia, hypoalbuminemia, renal/hepatic injury) 1
• Erythrocyte sedimentation rate (ESR) 1
• C-reactive protein (CRP) 1
• SARS-CoV-2 PCR and serology (serology is essential because MIS-C typically occurs 2-6 weeks post-infection when PCR may be negative) 1, 2

Critical Laboratory Thresholds Mandating Admission

Proceed immediately to hospital admission and Tier 2 evaluation if:

• CRP ≥10 mg/dL (commonly >20 mg/dL in MIS-C) 1, 2, 3
• Elevated ESR and/or CRP plus at least one of: lymphopenia (ALC <1,000/µL), neutrophilia, thrombocytopenia (<150,000/µL), hyponatremia (Na <135 mmol/L), or hypoalbuminemia 1
• Any evidence of renal or hepatic injury (even mild transaminase or creatinine elevation) 1, 2

Tier 2 Cardiac Evaluation (If Tier 1 Abnormal or High Clinical Suspicion)

Cardiac assessment is mandatory because 20-55% of MIS-C patients develop left-ventricular dysfunction and approximately 20% develop coronary artery abnormalities. 2

Required cardiac studies include:

• Electrocardiogram: up to 20% develop conduction abnormalities including atrioventricular block 1, 2
• Echocardiogram: assess ventricular function, coronary arteries, valvular status, and pericardial effusion 1, 2
• Cardiac biomarkers: troponin T and BNP/NT-proBNP 1, 2

Additional inflammatory markers for risk stratification:

• D-dimer, ferritin, lactate dehydrogenase, interleukin-6, fibrinogen, procalcitonin 1, 2

Outpatient Management (Only If All Criteria Met)

Outpatient evaluation may be appropriate only if all of the following are satisfied: 1, 3

• Child appears well with stable vital signs 1, 3
• No respiratory distress 1
• Normal mental status 1
• Adequate hydration (able to maintain oral intake) 1
• No concerning physical examination findings 1, 3
• Guaranteed close clinical follow-up within 24-48 hours 1, 3

Outpatient Supportive Care

If outpatient management is deemed safe:

• Fever management: acetaminophen or ibuprofen at standard pediatric dosing 2
• Adequate fluid intake to maintain hydration 2
• Activity restriction and rest 2
• Daily monitoring by caregivers for development of fever, worsening symptoms, or new concerning features 2, 3
• Re-evaluation within 24-48 hours either in-person or via telehealth 2, 3

Critical Pitfalls to Avoid

• Do not dismiss this as a benign viral illness: The combination of fever, headache, and positive COVID-19 test requires active screening for MIS-C, which can be rapidly fatal if untreated. 1, 2, 3

• A positive rapid COVID test does not exclude MIS-C: MIS-C typically occurs 2-6 weeks after initial SARS-CoV-2 infection, and both acute COVID-19 and post-infectious MIS-C can coexist. 1, 2

• Serology is essential: If MIS-C is suspected, SARS-CoV-2 serology must be obtained because PCR may be negative weeks after infection when MIS-C develops. 1, 2

• Rapid decompensation can occur: Maintain a low threshold for admission because specific risk factors for severe progression are not fully defined. 1, 2

• Cardiac complications are life-threatening: Up to 20% develop coronary artery abnormalities and 20-55% develop ventricular dysfunction, making early cardiac assessment critical. 2

• Headache with any additional systemic symptoms requires aggressive evaluation: Isolated headache may be benign, but headache plus fever mandates full MIS-C workup. 3

Multidisciplinary Consultation

If MIS-C is suspected or confirmed, engage: 1

• Pediatric rheumatology 1
• Pediatric cardiology 1
• Pediatric infectious disease 1
• Pediatric hematology 1
• Additional subspecialties as needed (neurology, nephrology, gastroenterology) 1

Alternative Diagnoses to Consider

While evaluating for MIS-C, also investigate other possible causes: 1

• Kawasaki disease (unrelated to SARS-CoV-2): fever ≥5 days plus conjunctivitis, oral changes, rash, extremity changes, or lymphadenopathy 1
• Bacterial infections: obtain blood cultures before antibiotics if fever of unknown origin 2
• Other viral infections: consider co-infections 4
• Malignancy or other inflammatory conditions 1